+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07884019

Preoperative Stereotactic Body Radiotherapy to Prevent Pancreatic Fistula After Pancreatoduodenectomy in High-Risk Patients A Randomized Controlled Multicenter Study

Led by Oulu University Hospital · Updated on 2026-10-20

70

Participants Needed

3

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

This research investigates the use of stereotactic body radiotherapy SBRT to reduce the risk of postoperative pancreatic fistula POPF in patients undergoing pancreatoduodenectomy who are at very high risk due to a soft pancreas and a small pancreatic duct diameter of 3 millimeters or less. The study compares SBRT before surgery versus conventional treatment to see if SBRT can induce pancreatic atrophy, which may decrease the chance of a serious pancreatic leak after surgery. The study involves multiple hospitals in Finland and focuses on patients with specific high-risk features for POPF. Participants are randomly assigned to one of two groups one group receives SBRT targeting the remnant pancreas with a total dose of 19.8 Gy delivered in three fractions 4 to 6 weeks before surgery, while the other group undergoes the standard pancreatoduodenectomy without preoperative radiotherapy. SBRT is a precise radiation method designed to cause fibrotic changes in the pancreas, potentially reducing its exocrine function and thus the risk of fistula development. The study evaluates the effects of SBRT on pancreatic tissue and function, surgical complications, and quality of life. Throughout the trial, participants are monitored for postoperative pancreatic fistula occurrence within 90 days after surgery, as well as other outcomes such as pancreatic fibrosis assessed by MRI and elastography, adverse events related to SBRT, surgical complications, mortality, hospital stay length, readmissions, pancreatic endocrine and exocrine function changes, and healthcare costs. Researchers also analyze radiological and tissue changes caused by SBRT. The total duration for each participant includes preoperative radiotherapy if assigned, surgery, and follow-up assessments extending at least three months after surgery.

CONDITIONS

Brief Title

Stereotactic Body Radiotherapy (SBRT) Induced Pancreatic Atrophy for Prevention of Post Operative Pancreatic Fistulae (POPF) After Pancreatoduodenectomy in Very High-Risk Patients (STEREOPANC)

Research Team

M

Minna Nortunen, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here